Group One Trading’s Gritstone bio, Inc. Common Stock GRTS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q4
Sell
-108,151
Closed -$62.7K 8164
2024
Q3
$62.7K Buy
108,151
+7,700
+8% +$4.32K ﹤0.01% 4495
2024
Q2
$62.1K Buy
+100,451
New +$84.9K ﹤0.01% 4355
2024
Q1
Sell
-187,324
Closed -$458K 8151
2023
Q4
$382K Buy
187,324
+152,747
+442% +$279K ﹤0.01% 3296
2023
Q3
$59.5K Sell
34,577
-134,930
-80% -$240K ﹤0.01% 4930
2023
Q2
$331K Sell
169,507
-17,918
-10% -$42K ﹤0.01% 3438
2023
Q1
$521K Buy
187,425
+178,777
+2,067% +$511K ﹤0.01% 2743
2022
Q4
$29.8K Sell
8,648
-2,163
-20% -$6.17K ﹤0.01% 5347
2022
Q3
$28K Sell
10,811
-23,230
-68% -$74K ﹤0.01% 5870
2022
Q2
$82K Sell
34,041
-5,713
-14% -$15K ﹤0.01% 5168
2022
Q1
$164K Buy
39,754
+29,532
+289% +$156K ﹤0.01% 5012
2021
Q4
$131K Buy
+10,222
New +$113K ﹤0.01% 5488
2021
Q3
Sell
-913
Closed -$8.31K 8924
2021
Q2
$8K Buy
913
+887
+3,412% +$8.2K ﹤0.01% 7623
2021
Q1
$0 Buy
+26
New +$358 ﹤0.01% 8131

Other funds holding GRTS

Group One Trading's GRTS Position: Q4 2024 in Review

Group One Trading sold out of Gritstone bio, Inc. Common Stock (GRTS) in Q4 2024, closing a stake of 108,151 shares — an estimated $62.7K sold.

Group One Trading first reported a position in GRTS in Q1 2021 and held it in 13 quarters. The position peaked at $521K in Q1 2023. 6 funds tracked by Wall St. Rank hold GRTS as of Q4 2024.

  • Group One Trading reported no remaining Gritstone bio, Inc. Common Stock position as of Q4 2024 after selling out during the quarter.
  • Group One Trading sold 108,151 Gritstone bio, Inc. Common Stock shares in Q4 2024, an estimated $62.7K.
  • Group One Trading first reported a position in Gritstone bio, Inc. Common Stock in Q1 2021 and held it in 13 quarters.
  • Group One Trading's Gritstone bio, Inc. Common Stock position peaked at $521K in Q1 2023.
  • 6 funds tracked by Wall St. Rank held Gritstone bio, Inc. Common Stock as of Q4 2024.

Based on Group One Trading's 13F filing for Q4 2024, filed 14 Feb 2025.